Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Gil Bar‐Sela
Cannabis Impacts Tumor Response Rate to Nivolumab in Patients With Advanced Malignancies
Oncologist
Cancer Research
Medicine
Oncology
Related publications
Effect of Trabectedin on the QT Interval in Patients With Advanced Solid Tumor Malignancies
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
A Phase 1 Study of Cetuximab and Lapatinib in Patients With Advanced Solid Tumor Malignancies
Cancer
Cancer Research
Oncology
Nivolumab Improves Survival for Patients With Advanced Lung Cancer
Cancer
Cancer Research
Oncology
182P: Intracranial Response to Nivolumab in NSCLC Patients With Untreated or Progressing CNS Metastases
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Evaluating the Safety and Efficacy of Nivolumab in Patients With Advanced Hepatocellular Carcinoma: Evidence to Date
OncoTargets and Therapy
Oncology
Pharmacology
A Phase I Study of Indoximod in Patients With Advanced Malignancies
Oncotarget
Oncology
Predictors of Survival in Patients With Advanced Gastrointestinal Malignancies Admitted to the Intensive Care Unit
Oncologist
Cancer Research
Medicine
Oncology
Circulating Tumor DNA Evaluated by Next-Generation Sequencing Is Predictive of Tumor Response and Prolonged Clinical Benefit With Nivolumab in Advanced Non-Small Cell Lung Cancer
OncoImmunology
Oncology
Allergy
Immunology
Outcome of Vulvar Reconstruction in Patients With Advanced and Recurrent Vulvar Malignancies
BMC Cancer
Cancer Research
Oncology
Genetics
